Anti-APC-CD3 was used to label CD3-tumor cells at the same time57. exhibits the ability to elicit cytotoxic T lymphocyte-mediated antitumor immunity via B7H3 internalization. Together, these findings offer a rationale for targeting glycosylated B7H3 as a potential strategy for immunotherapy. Subject terms:Tumour immunology, T cells, Cancer therapy, Epigenetics Glycosylated asparagine residues that mediate the function of the B7H3 protein are unclear. Here the authors identify the important N-glycosylation sites for B7H3 cell surface localization and T cell inhibition, followed by the development of N91/309 and N104/322 preferentially targeting monoclonal antibody manifesting enhanced antitumor immunity. == Introduction == N-Glycosylation is an important posttranslational modification in which carbohydrate moieties are attached to proteins1. These glycans are covalently attached to asparagine (Asn) residues in an N-glycosylation consensus sequence (NXT motif, Asn-X-Ser/Thr, where X may be any amino AG 555 acid except for Pro)2. N-glycosylation plays critical roles in many biochemical and biological events, such as protein folding, degradation, cellular localization, intracellular transport and proteinprotein interactions35. This type of posttranslational modification is first catalyzed by an oligosaccharyl transferase (OST) complex that transfers a preformed oligosaccharide to an asparagine side chain acceptor in the endoplasmic reticulum (ER). Further processing occurs in the Golgi apparatus via a sequential glycosidase- and glycotransferase-mediated glycoprotein biosynthesis pathway6. The ER is the major site of membrane protein folding, assembly, and maturation. When a protein is usually misfolded or when an Rabbit polyclonal to ANXA8L2 abnormal glycan structure is present, the protein is recognized by the lectin ER-degradation enhancing a-mannosidase-like protein (EDEM), undergoes retrograde translocation from the ER to the cytosol, and is then degraded by endoplasmic reticulum-associated protein degradation (ERAD) via the ubiquitinproteasome system for ER quality control7,8.This process requires ER membraneembedded protein complexes, such as HRD1 and SEL1L, and the ubiquitin-dependent segregase VCP (valosin-containing protein, also known as p97)911. Many membrane proteins and receptors are N-glycosylated, and this modification plays an AG 555 essential role in membrane protein function12. For instance, the glycan on N89, among the three glycans present on inducible co-stimulator (ICOS), is required for proper ICOS protein folding in the ER and its intracellular trafficking and ligand binding activity13. Therefore, it is important to determine the specific N-glycans of membrane proteins that are essential for proper ER quality control, membrane trafficking and protein activities. B7 homolog 3 protein (B7H3), also known as CD276, is a type I transmembrane protein belonging to the B7 immunoglobin superfamily. 4IgB7H3 (encoding 534 amino acids) with two identical pairs of extracellular IgV-like and IgC-like domains is the predominant isoform in humans. B7H3 in mouse is AG 555 usually expressed only as the 2IgB7H3 isoform (encoding 316 amino acids) with one pair of extracellular IgV-like and IgC-like domains14. Human B7H3 is usually highly glycosylated, and widely overexpressed in many solid cancers but exhibit very low expression in matched normal tissues. Previous studies have shown that B7H3 plays important roles in tumor cell migration, proliferation, invasion, and angiogenesis and plays key roles in cancer cell escape from immune surveillance1517. It has been verified that there are four pairs of Asn N-glycosylation sites (N91/N309, N104/N322, N189/N407, and N215/N433) in B7H3 in oral squamous cells and breast cancer cells. And this modification plays an important role in the poor prognosis of patients and is necessary for the inhibitory effect of B7H3 on the activity of cytotoxic T cells18,19. However, it remains largely unknown whether all glycosylation sites of B7H3 contribute to glycan-mediated functions or whether specific positions have individual roles. In this work, we clarify the biological roles of N-glycans on B7H3 using a series of glycosylation-defective B7H3 mutant proteins. We reveal that this N-glycans attached to N91/309 and N104/322 are essential for B7H3 surface expression and immune evasion, with their absence triggering ER retention and ERAD-dependent elimination. Notably, we develop an optimized monoclonal antibody, Ab-82, that selectively targets AG 555 these glycosylation sites, inducing B7H3 internalization and degradation while enhancing antitumor immunity through cytotoxic T cell activation. This study provides a substantial contribution to the current mechanistic understanding of the necessity and potential functions of a specific N-glycan among the multiple glycans of B7H3 and a potential strategy for eliciting an antitumor effect. == Results == == Identification of the vital N-glycosylation sites that maintain B7H3 protein stability == N-linked glycosylation occurs specifically at the NXT motif (Asn-X-Ser/Thr sequon). In the consensus sequence, N represents asparagine (Asn) residue with forming an N-glycosidic bond, X represents any amino acid except proline (Pro), and.
